Social Cognitive Training for Psychosis: Treatment Development
Primary Purpose
Schizophrenia, Psychosis
Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
social cognitive training
Sponsored by
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring schizophrenia, treatment, social cognition
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of schizophrenia or other psychotic disorder
- Age between 18 and 55
- Psychiatrically stable
- Clinician agrees to individual's participation in study
- English as primary language
Exclusion Criteria:
- current (past 30 days) symptoms of alcohol abuse/dependence
- developmental disability
- severe auditory/visual impairment or known neurological disorder
- participant has a legal conservator
Sites / Locations
- VA Connecticut Healthcare System
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
social cognitive training
Arm Description
Outcomes
Primary Outcome Measures
social cognition
AIHQ Eyes Task Hinting Task IPSAQ
Secondary Outcome Measures
Full Information
NCT ID
NCT01579422
First Posted
April 10, 2012
Last Updated
January 11, 2016
Sponsor
Yale University
Collaborators
National Institute of Mental Health (NIMH)
1. Study Identification
Unique Protocol Identification Number
NCT01579422
Brief Title
Social Cognitive Training for Psychosis: Treatment Development
Official Title
Social Cognitive Training for Psychosis: Phase I Treatment Development
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
National Institute of Mental Health (NIMH)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary aim of this proposal is to develop, refine, manualize and assess the feasibility and preliminary efficacy of a brief, narrowly-focused social cognitive intervention for individuals with psychosis. The intervention will focus on helping individuals interpret social situations, specifically the intentions and feelings of others.
Study methods include preliminary treatment and manual development based on series of uncontrolled cases, manual refinement, and a small feasibility/efficacy trial of the newly developed intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Psychosis
Keywords
schizophrenia, treatment, social cognition
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
77 (Actual)
8. Arms, Groups, and Interventions
Arm Title
social cognitive training
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
social cognitive training
Intervention Description
social cognitive training, 8-10 sessions
Primary Outcome Measure Information:
Title
social cognition
Description
AIHQ Eyes Task Hinting Task IPSAQ
Time Frame
change from baseline to approximately 6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of schizophrenia or other psychotic disorder
Age between 18 and 55
Psychiatrically stable
Clinician agrees to individual's participation in study
English as primary language
Exclusion Criteria:
current (past 30 days) symptoms of alcohol abuse/dependence
developmental disability
severe auditory/visual impairment or known neurological disorder
participant has a legal conservator
Facility Information:
Facility Name
VA Connecticut Healthcare System
City
West Haven
State/Province
Connecticut
ZIP/Postal Code
06516
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Social Cognitive Training for Psychosis: Treatment Development
We'll reach out to this number within 24 hrs